Eric Pham

Eric Pham, PhD, is currently the Managing Director at Avego, specializing in mid to late stage private biotech investments. They serve as a Board Member at TRexBio and have held several Board Observer roles, including with MapLight Therapeutics and ANAVEON AG. Previously, Eric worked as the Vice President of Healthcare Opportunities at Blue Owl Capital and gained experience as a Senior Analyst at Roivant Sciences, as well as in various positions within Cowen Inc. They hold a Ph.D. from the University of Houston and a B.A. from the University of California, Berkeley.